DCF — SWEDISH MEDICAL CENTER
Enterprise Value: $-3.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-3.2B
Enterprise Value
$-983.2M
PV of Cash Flows
$-2.2B
PV of Terminal Value
$-3.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $1.4B | $-207.8M | -15.0% | $-267.7M | $-243.3M |
| Year 2 | $1.5B | $-199.5M | -14.0% | $-261.1M | $-215.8M |
| Year 3 | $1.5B | $-190.5M | -13.0% | $-254.0M | $-190.8M |
| Year 4 | $1.5B | $-188.5M | -12.0% | $-253.9M | $-173.4M |
| Year 5 | $1.6B | $-190.1M | -12.0% | $-257.5M | $-159.9M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-3.2B. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.4B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.15198901978453525
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5